These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 474380)

  • 1. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
    Levites R; Anderson GJ
    Am Heart J; 1979 Sep; 98(3):339-44. PubMed ID: 474380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
    Befeler B; Castellanos A; Wells DE; Vagueiro MC; Yeh BK
    Am J Cardiol; 1975 Feb; 35(2):282-7. PubMed ID: 1119389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and antiarrhythmic effects of propranolol in canine acute myocardial ischemia.
    Kupersmith J; Shiang H; Litwak RS; Herman MV
    Circ Res; 1976 Apr; 38(4):302-7. PubMed ID: 1260972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion.
    Levites R; Bodenheimer MM; Helfant RH
    Circulation; 1975 Dec; 52(6):1050-5. PubMed ID: 810264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of disopyramide on reperfusion arrhythmias in dogs.
    Chagnac A; Pelleg A; Belhassen B; Lubliner J; Vidné B; Laniado S
    J Cardiovasc Pharmacol; 1982; 4(6):994-8. PubMed ID: 6185794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of coronary occlusion and reperfusion. Observations of dispersion of refractoriness and ventricular automaticity.
    Levites R; Banka VS; Helfant RH
    Circulation; 1975 Nov; 52(5):760-5. PubMed ID: 1175258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of disopyramide in patients with bundle branch block.
    Desai JM; Scheinman M; Peters RW; O'Young J
    Circulation; 1979 Feb; 59(2):215-25. PubMed ID: 758989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct electrophysiologic effects of disopyramide phosphate in the transplanted human heart.
    Bexton RS; Hellestrand KJ; Cory-Pearce R; Spurrell RA; English TA; Camm AJ
    Circulation; 1983 Jan; 67(1):38-45. PubMed ID: 6401173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiology of disopyramide in man.
    Ross D; Vohra J; Cole P; Hunt D; Sloman G
    Aust N Z J Med; 1978 Aug; 8(4):377-83. PubMed ID: 282851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between ventricular refractoriness and regional myocardial blood flow after acute coronary occlusion.
    Batsford WP; Cannom DS; Zaret BL
    Am J Cardiol; 1978 May; 41(6):1083-8. PubMed ID: 665512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Am J Cardiol; 1980 Nov; 46(5):792-9. PubMed ID: 7435389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
    Kobayashi A; Watanabe H; Yamazaki N
    Jpn Heart J; 1988 Nov; 29(6):831-40. PubMed ID: 3241336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1979 Jun; 66(2):241-50. PubMed ID: 465877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium antagonists and lidocaine on conduction delay induced by acute myocardial ischemia in dogs.
    Nakaya H; Hattori Y; Kanno M
    Jpn J Pharmacol; 1980 Oct; 30(5):587-97. PubMed ID: 7206368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic and blood-flow responses in the endocardium and epicardium to disopyramide and MS-551 during myocardial ischemia in the dog.
    Tanabe T; Iwamoto T; Iwata O; Aikawa M; Kusuzaki S; Handa S; Shinozaki Y; Mori H
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):275-86. PubMed ID: 10445680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.
    Tsuchioka Y; Mitsuda H; Eno S; Fujitani K; Furuta Y; Yoshida M; Miyoshi A; Tateishi H; Satou H
    Jpn Circ J; 1982 Jul; 46(7):693-700. PubMed ID: 6808188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.